The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment

Kisha I Coa, Joel B Epstein, David Ettinger, Aminah Jatoi, Kathy McManus, Mary E Platek, Wendy Price, Meghan Stewart, Theodoros N Teknos, Bruce Moskowitz, Kisha I Coa, Joel B Epstein, David Ettinger, Aminah Jatoi, Kathy McManus, Mary E Platek, Wendy Price, Meghan Stewart, Theodoros N Teknos, Bruce Moskowitz

Abstract

Patients undergoing cancer treatment experience a multitude of symptoms that can influence their ability to complete treatment as well as their quality of life during and after treatment. This cross-sectional study sought to describe the dietary changes experienced by cancer patients and to identify associations between these changes and common treatment symptoms. A convenience sample of 1199 cancer patients aged 18 yr and older undergoing active treatment were recruited from 7 cancer centers to complete a self-administered paper-and-pencil survey. Descriptive analyses were conducted to estimate prevalence of dietary changes and chi-squared tests were used to examine associations between dietary changes and health outcomes. Approximately 40% of patients reported a decreased appetite since beginning treatment, and 67.2% of patients reported at least 1 chemosensory alteration. Increased taste sensitivities were more common than decreased taste sensitivities, with increased sensitivity to metallic being the most common taste sensitivity (18.6%). Patients also had increased sensitivities to certain smells including cleaning solutions (23.4%), perfume (22.4%), and food cooking (11.4%). Patients reported a wide range of food preferences and aversions. Patients who had less energy or lost weight since beginning treatment were more likely than others to report treatment-related dietary changes.

References

    1. Howlader N. Noone A. Krapcho M. Garshell J. Miller D, et al. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD: National Cancer Institute; 2013.
    1. Barbera L. Seow H. Howell D. Sutradhar R. Earle C, et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer. 2010:5767–5776.
    1. Servaes P. Verhagen C. Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. European Journal of Cancer. 2002:27–43.
    1. Teunissen SC. Wesker W. Kruitwagen C. de Haes HC. Voest EE, et al. Symptom prevalence in patients with incurable cancer: a systematic review. Journal of Pain and Symptom Management. 2007:94–104.
    1. Tisdale MJ. Cachexia in cancer patients. Nature Reviews Cancer. 2002:862–871.
    1. Curt GA. Breitbart W. Cella D. Groopman JE. Horning SJ, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. The Oncologist. 2000:353–360.
    1. Gupta D. Lis CG. Grutsch JF. The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. Journal of Pain and Symptom Management. 2007:40–47.
    1. Beaver ME. Matheny KE. Roberts DB. Myers JN. Predictors of weight loss during radiation therapy. Otolaryngology—Head and Neck Surgery. 2001:645–648.
    1. Capuano G. Grosso A. Gentile PC. Battista M. Bianciardi F, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head & Neck. 2008:503–508.
    1. Kroenke CH. Chen WY. Rosner B. Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. Journal of Clinical Oncology. 2005:1370–1378.
    1. Thivat E. Therondel S. Lapirot O. Abrial C. Gimbergues P, et al. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer. 2010:648.
    1. Ravasco P. Aspects of taste and compliance in patients with cancer. European Journal of Oncology Nursing. 2005:S84–S91.
    1. Grant M. Kravits K. Symptoms and their impact on nutrition. Seminars in Oncology Nursing. 2000. pp. 113–121.
    1. Brisbois TD. de Kock IH. Watanabe SM. Baracos VE. Wismer WV. Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. Journal of Pain and Symptom Management. 2011:673–683.
    1. Brisbois TD. Hutton JL. Baracos VE. Victoria W. Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer-: an argument for the application of sensory science. Journal of Palliative Care. 2006:111–114.
    1. Hutton JL. Baracos VE. Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. Journal of Pain and Symptom Management. 2007:156.
    1. Zabernigg A. Gamper E-M. Giesinger JM. Rumpold G. Kemmler G, et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect. The Oncologist. 2010:913–920.
    1. Hovan AJ. Williams PM. Stevenson-Moore P. Wahlin YB. Ohrn KE, et al. A systematic review of dysgeusia induced by cancer therapies. Supportive Care in Cancer. 2010:1081–1087.
    1. Boltong A. Keast R. The influence of chemotherapy on taste perception and food hedonics: A systematic review. Cancer Treatment Reviews. 2012:152–163.
    1. Paccagnella A. Morello M. Da Mosto MC. Baruffi C. Marcon ML, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Supportive Care in Cancer. 2010:837–845.
    1. Schiffman S. Sattely-Miller E. Taylor E. Graham B. Landerman L, et al. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. The Journal of Nutrition, Health & Aging. 2006:439–454.
    1. Caro MMM Laviano A. Pichard C. Impact of nutrition on quality of life during cancer. Current Opinion in Clinical Nutrition & Metabolic Care. 2007:480–487.
    1. Wismer WV. Assessing alterations in taste and their impact on cancer care. Current Opinion in Supportive and Palliative Care. 2008:282–287.
    1. Hutton JL. Martin L. Field CJ. Wismer WV. Bruera ED, et al. Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. The American Journal of Clinical Nutrition. 2006:1163–1170.
    1. Bozzetti F. Mariani L. Vullo SL. Amerio ML. Biffi R, et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Supportive Care in Cancer. 2012:1919–1928.
    1. Epstein J. Phillips N. Parry J. Epstein M. Nevill T. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 2002:785–792.
    1. Olofsson JK. Nordin S. Gender differences in chemosensory perception and event-related potentials. Chemical Senses. 2004:629–637.
    1. Glanville EV. Kaplan AR. Fischer R. Age, sex and taste sensitivity. Journal of Gerontology. 1964:474–478.
    1. Cowart BJ. Relationships between taste and smell across the adult life span. Annals of the New York Academy of Sciences. 1989:39–55.
    1. Fearon K. Strasser F. Anker SD. Bosaeus I. Bruera E, et al. Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology. 2011:489–495.
    1. Doyle C. Kushi LH. Byers T. Courneya KS. Demark-Wahnefried W, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA: A Cancer Journal for Clinicians. 2006:323–353.
    1. Ravasco P. Monteiro-Grillo I. Vidal PM. Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. Journal of Clinical Oncology. 2005:1431–1438.
    1. Bernhardson B-M. Tishelman C. Rutqvist LE. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. Journal of Pain and Symptom Management. 2007:403–412.

Source: PubMed

3
Abonnieren